Iqvia Holdings (IQV) EBT Margin (2012 - 2026)
Iqvia Holdings (IQV) posted EBT Margin of 6.89% for Q2 2026, down 12.79% sequentially from 7.9% in Q1 2026, and down 115.0% YoY from 45.94% in Q2 2025.
Iqvia Holdings (IQV) EBT Margin (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported EBT Margin for 15 years, with the latest figure at 6.89% in Q2 2026.
- Quarterly EBT Margin fell 115.0% year-over-year to 6.89% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 9.27% (down 53.0% YoY) and the FY2025 annual result came in at 9.75%, down 108.0% from the prior year.
- EBT Margin slipped to 6.89% in Q2 2026 per IQV's latest filing, from 7.9% in the prior quarter.
- Over five years, EBT Margin peaked at 13.74% in Q4 2024 and troughed at 6.89% in Q2 2026.
- A 5-year average of 9.65% and a median of 9.49% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin soared 410 bps in 2024, then plunged 339 bps in 2025.
- Over 5 years, EBT Margin stood at 7.35% in 2022, then jumped by 31 bps to 9.64% in 2023, then soared by 43 bps to 13.74% in 2024, then fell by 10 bps to 12.31% in 2025, then tumbled by 44 bps to 6.89% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 6.89%, 7.9%, and 12.31% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 9.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.89% |
| Mar 31, 2026 | 7.90% |
| Dec 31, 2025 | 12.31% |
| Sep 30, 2025 | 9.95% |
| Jun 30, 2025 | 8.04% |
| Mar 31, 2025 | 8.44% |
| Dec 31, 2024 | 13.74% |
| Sep 30, 2024 | 8.96% |
| Jun 30, 2024 | 11.43% |
| Mar 31, 2024 | 9.10% |
| Dec 31, 2023 | 9.64% |
| Sep 30, 2023 | 9.34% |
| Jun 30, 2023 | 10.06% |
| Mar 31, 2023 | 9.91% |
| Dec 31, 2022 | 7.35% |
| Sep 30, 2022 | 10.11% |
| Jun 30, 2022 | 9.26% |
| Mar 31, 2022 | 11.21% |
| Dec 31, 2021 | 10.34% |
| Sep 30, 2021 | 8.05% |